Treatment of Diabetes Learning Objectives By the end of this session you should be able to: Define the goals of therapy for type 1 and 2 diabetes in accordance with the American Diabetes Association Clinical Practice Guidelines 2020 & 2021, including the recently updated indications for: Metformin GLP-1 receptor agonists SGLT-2 inhibitors List the categories of pharmacologic agents used in the management of patients with type 1 and 2 diabetes Explain the following for each drug category: mechanisms of action indications contraindications potential side effects major advantages /disadvantages Identify the drug category that individual diabetic medications belong to based upon their non-proprietary names (e.g
This article reviews mechanistic insights, potential domains of implication in research, and speculative directions for the BPC-157 / TB-500 blend
Glutathione is relatively unstable once reconstituteduse within 23 weeks for optimal potency [6]
For approximately 70% of patients with psychotic features, first- and second-generation antipsychotic drugs have similar efficacy for treating positive symptoms
WAKIX is FDA-approved for the treatment of excessive daytime sleepiness or cataplexy in adult patients with narcolepsy and for the treatment of EDS in pediatric patients 6 years of age and older with narcolepsy, but it is not yet approved for Prader-Willi syndrome and remains under evaluation for this condition
Both Wegovy and Ozempic use gradual dose-increasing schedules to minimise side effects